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BACKGROUND Geriatric conditions (eg, cognitive impairment,
frailty) are increasingly recognized for their impact on clinical
and quality-of-life outcomes in older patients with cardiovascular
disease, but are not systematically assessed in the context of clin-
ical visits owing to time constraints.
OBJECTIVE To examine feasibility of remote monitoring of the
physical, cognitive, and psychosocial status of older adults with
atrial fibrillation (AF) via a novel smartphone app over 6 months.
METHODS Forty participants with AF and eligible for anticoagula-
tion therapy (CHA2DS2VASc2) enrolled in an ongoing cohort study
participated in a mobile health pilot study. A 6-component geriatric
assessment, including validated measures of frailty, cognitive func-
tion, social support, depressive symptoms, vision, and hearing, was
deployed via a smartphone app and 6-minute walk test was
completed using a Fitbit. Adherence to mobile assessments was
examined over 6 months.
RESULTS Participants were an average of 71 years old (range 65–
86 years) and 38% were women. At 1 month, 75% (30/40) of
participants completed the app-based geriatric assessment and
63% (25/40) completed the 6-minute walk test. At 6 months,
52% (15/29) completed the geriatric assessment and 28% (8/29)
completed the walk test. There were no differences in demographic,
clinical, or psychosocial factors between participants who
completed the surveys at 6 months and those who did not. Partici-
pants, on average, required less than 10 minutes of telephone sup-
port over the 6-month period.
CONCLUSION It is feasible, among smartphone users, to use a mo-
bile health app and wearable activity monitor to conduct serial geri-
atric assessments in older patients with AF for up to 6 months.
KEYWORDS Atrial fibrillation; Geriatric assessment; Mobile health
application; Older adults
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Atrial fibrillation (AF) is the most prevalent heart rhythm dis-
order in the world, affecting an estimated 8 million Ameri-
cans currently and over 30 million people globally.1 The
condition is associated with a 5-fold increased risk for stroke
as well as an increase in risk for dementia, hospitalization,
and mortality.2 In the era of COVID-19, clinical and research
visits with patients with AF and other cardiovascular diseases
may, for some time, take the form of telemedicine and remote
visits.3 Although this poses some challenges to clinical and
research operations, there may also be opportunities associ-
ated with this new form of communication with patients.
These telemedicine modalities provide the opportunity to
assess factors that may not fit into the time constraints of a
typical in-person clinical encounter and the additional benefit
of enabling assessment of patient behavior and experiences in
real time, in an at-home setting that may be more reflective of
the patient’s day-to-day state.
Geriatric assessments, including measures of cognitive
function, frailty, social isolation and depression, are increas-
ingly recognized for their impact on clinical outcomes in pa-
tients with AF. For example, cognitive impairment (CI),
prevalent in up to half of patients with AF, is associated
with less successful anticoagulation (AC) and poorer clinical
outcomes.4–7 In addition, CI, lack of social support, fall risk,
and frailty are associated with poor adherence to AC and
to lower time in therapeutic range.8–10 The importance of
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these factors was recognized in the 2019 American College
of Cardiology/American Heart Association (ACC/AHA)
AF Treatment Guidelines, which emphasize the need to
weigh geriatric conditions, including CI and physical
frailty, in therapeutic decision-making.2 Despite the recog-
nized importance of these factors, geriatric conditions are
not systematically assessed in all patients owing to time con-
straints or lack of availability of standardized measures with
clear administration, scoring, and interpretation criteria.11
In the context of a diverse cohort of older patients with
AF, we tested the feasibility of a geriatric assessment
captured via an app and Fitbit wrist-based wearable activity
monitor (Fitbit, Inc, San Francisco, CA) over a 6-month
period. Establishing the feasibility of serial assessments of
a systematic geriatric assessment via an app would be useful
in clinical and research contexts. Clinically, routine assess-
ment of cognitive function, frailty, social support, and
depression could help identify a subset of patients at high
risk for poor outcomes who may need more surveillance
and tailored education. Remote geriatric assessments would




The present study is a mobile health (mHealth) pilot study
nested within the ongoing Systematic Assessment of Geri-
atric Elements in Atrial Fibrillation (SAGE-AF) prospective
cohort study of 1244 older patients with AF. Details of the
SAGE-AF study have been previously described.4 Briefly,
to be eligible for SAGE-AF, participants must have AF (par-
ticipants were considered to have AF if the arrhythmia was
present on an electrocardiogram or Holter monitor or if AF
was noted in any clinic note or hospital record), be aged 65
years or older, and have a CHA2DS2VASC risk score 2.
Participants are not eligible for enrollment if they have docu-
mentation of an absolute contraindication to AC, if they have
an indication for AC other than AF (ie, mechanical heart
valve, deep venous thrombosis, or pulmonary embolism), if
they do not demonstrate capacity to provide informed con-
sent as assessed by a capacity instrument that combines direct
questions about their understanding of study participation
with interviewer observations of the patient,12 if they do
not speak English, or if they have a planned invasive proced-
ure with high risk for uncontrollable bleeding. Participants in
this mHealth pilot study had the additional inclusion criteria
of ownership of an Apple iOS or Android smartphone. This
study has been approved by the University of Massachusetts
Medical School institutional review board. The research re-
ported in this paper adhered to the guidelines established
by the Declaration of Helsinki as revised in 2013.
Study procedures
Participants were recruited into the pilot mHealth study over
8 months during a cardiology/internal medicine clinic visit.
All SAGE-AF participants who indicated owning a smart-
phone at enrollment were eligible for the pilot study. Of
those, 104 were approached and 40 consented. Study staff
helped download the MyDataHelps and Fitbit apps onto
participants’ smartphones. Fitbit Charge 2 heart rate devices
(Fitbit Inc) were also given to participants at the time of
enrollment and training was conducted on the Fitbit device
and surveys. Training took an average of 15 minutes per
participant.
Mobile health survey components
Validated assessments of depression,13 vision, hearing, and
social isolation14 were adapted for mobile use by entering
each question and all answer options into the MyDataHelps
online survey designer (Figure 1) and were completed at
baseline and at 30, 60, 90, 120, 150, and 180 days. Social
support was measured by the 5-item modified version of
the Social Support Scale and the 6-item Social Network Scale
(range 0–30) to assess breadth and depth of social support
available to participants,14 with a score of 12 used to indicate
social isolation. The Patient Health Questionnaire (PHQ-9,
range 0–27) was used to assess depressive symptoms,13
with 5 used as a cut point for high depressive symptoms. Pa-
tients’ self-reported vision and hearing status are based on
standardized questionnaires. Participants interacted with the
questionnaires by clicking their phone screen and were
only presented with 1 question at a time within each question-
naire. The cognitive assessments (modified versions of the
Stroop test and Trail Making test, Part B) were completed
SNAPSHOT SUMMARY
In this pilot study of older participants with atrial fibrilla-
tion, we show it is feasible to administer a full geriatric
assessment remotely multiple times over a 6-month
period in a range of patients, including the oldest old
and those with cognitive and functional impairments.
KEY FINDINGS
 In this pilot study of older participants with atrial fibril-
lation (AF), we found it is feasible to administer a full
geriatric assessment remotely multiple times over a
6-month period.
 These assessments are feasible with minimal support in
a range of patients, including the oldest old and those
with cognitive and functional impairments.
 These results lay the groundwork for larger-scale studies
of how remote geriatric assessments could be incorpo-
rated into in-office and telemedicine management of
patients with AF or into large-scale cohort studies or
clinical trials.
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and timed. In the Stroop test, the participant is shown a series
of words that are displayed in color and must select the first
letter of the color’s name.15 The number of errors and the
time to complete the test is recorded. In the Trail Making
test, the participant connects a series of labeled circles, in or-
der.16 The number of errors and the time to complete the test
is recorded. The frailty measure was adapted from the FRAIL
questionnaire, a 5-item self-reported frailty index that has
been validated against a myriad of well-established indicators
of frailty, such as activities of daily living, physical perfor-
mance, and blood tests.17 The measures were deployed to
participants via the MyDataHelps app, along with automated
personalized messages prompting completion of measures at
baseline and every 30 days for the study duration.
Six-minute walk test
Participants in the mHealth pilot completed an in-clinic
6-minute walk test (6MWT) at the time of enrollment and
were asked to complete an at-home 6MWT every 30 days
by wearing their Fitbit device and using an automated text
message service that communicated the start and end times
of the walk test to study staff. The automated text message
service prompted participants to complete a walk test each
month with the message, “It’s time to complete your
6-minute walk test! When you are ready for your walk, please
find a flat surface and reply ‘walktest.’ Text ‘help’ if you need
assistance.” Participants responded to the automated message
when they were ready to start their walk. They received start
and stop prompts at the beginning and end of 6 minutes.
These automated prompts did not require time from staff to
send to participants. Participants were initially followed
through the mobile technologies for 30 days; however, after
11 participants had been enrolled and completed the 30-day
follow-up, we modified the study protocol to assess feasi-
bility of serial mobile assessments over a longer follow-up
period of 180 days. An additional 29 participants were
enrolled after this change to the study design. Participants
were provided with study staff contact info if they needed
support with using the app or devices.
The study staff recorded the reason for each call received
in order to garner additional insights regarding the potential
challenges and facilitators of implementing these remote as-
sessments within our study cohort.
Other study variables
All SAGE-AF participants complete a guided interview that
includes demographics, disease-specific health-related qual-
ity of life,18 a 6-component geriatric assessment using
validated measures of frailty,19 cognitive function,20 social
support,14 depressive symptoms,13 vision, and hearing. His-
tory of heart failure, bleeding, and stroke were abstracted
from the medical record by trained abstractors.
Results
Between August 2018 and March 2019, a total of 40 partici-
pants were enrolled into the m-SAGE pilot in the context of
a SAGE-AF study visit and completed an in-person geriatric
assessment per SAGE-AF protocol. Average age of
participants was 70.9 (standard deviation [SD] 5 4.8, range
65–86) years, 38% were female, and 95% were white
(Table 1). Geriatric impairments were common among
m-SAGE participants, with half (53%) falling into the pre-
frail category and 5% categorized as frail.More than 1 in 6 par-
ticipants (18%) were cognitively impaired, and approximately
one-quarter (25%) reported high depressive symptoms.
Twenty-nine of the 40 participants were offered participation
in an extended, 6-month follow-up assessment. Compared to
those enrolled in the extended follow-up, those enrolled in
only the 1-month follow-up had higher levels of depression,
anxiety, and frailty (all P  .05).
The baseline surveys were completed using the m-SAGE
app by 93% (37/40) of participants, while 75% (30/40)
Figure 1 Application screenshots.
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completed the day 30 surveys, 72% (21/29) the day 60 sur-
veys, 66% (19/29) the day 90 surveys, 55% (16/29) the day
120 surveys, 52% (15/29) the day 150 surveys, and 52%
(15/29) the day 180 surveys (Figure 2). We also examined
completeness of surveys, to determine whether the mHealth
battery was too long, and patterns of missing on specific tests,
to determine whether 1 measure was problematic for partici-
pants and thus often skipped.We found that with the exception
of 2 participants, the full battery of surveys was completed
once started, suggesting that the mHealth battery was not
too long. In the 2 participants who did not complete the full
survey, different measures were skipped, indicating that there
was not 1 “problematic”measure. In general, once participants
began the mHealth surveys, they completed all study assess-
ments. Partial completionwas uncommon (n5 2) and skipped
assessments were not restricted to a single survey measure. It
took participants an average of 23minutes to complete the sur-
veys (range 5 9–81 minutes). All participants completed an
in-clinic 6MWT at baseline, while 63% (25/40) completed
the at-home day 30 6MWT. More than half of participants
completed the at-home day 60 (59%; 17/29) and day 90
(55%; 16/29) 6MWT, just under half were adherent at day
120 (48%; 14/29) and day 150 (45%; 13/29), and 28% (8/
29) completed the day 180 6MWT. At 6 months, 40% (6/
15) of those who completed surveys also completed a
6MWT, and 14% (2/14) of those who did not complete sur-
veys completed a 6MWT (P5 .12). There were no significant
sociodemographic (age, sex, race, marital status, education) or
clinical (AF type, CHA2DS2VASc score, bothered by 1 AF
symptom in past 4 weeks, anticoagulant status, past medical
history [heart failure, hypertension, type II diabetes, bleeding,
dyslipidemia, stroke]) differences between those who
completed the surveys and walk test at 6 months and those
who did not (all P . .05).
Because there were baseline differences in several geriatric
elements between participants enrolled in the 1-month
follow-up (n 5 11) and those enrolled in the 6-month
follow-up (n5 29), we also examined adherence only among
those in the extended follow-up. When we restricted the
sample to only those enrolled in the 6-month follow-up, adher-
ence rates were similar, with 90% (26/29) of participants
completing all baseline surveys (compared to 93%; 37/40;
P 5 .65), 76% (22/29) completing all day 30 surveys
(compared to 75%; 30/40; P 5 .92), and 62% (18/29)
completing the day 30 6MWT (compared to 63%; 25/40; P
5 .93).
We also captured information about the amount and type
of telephone support provided to study participants by study
staff over the 6-month study period. Two-thirds (n 5 26;
65%) of participants called 2 times or less for support with
the mHealth technologies over the 6-month study period
(median 5 2; range 5 0-26; Q1 5 1; Q3 5 5). Three-
quarters (n 5 30; 75%) of participants called 3 times or
less over the 6-month course of study. The primary reasons
participants called were for assistance with Fitbit devices
(26% of calls; 28/109), account login help for Fitbit and
MyDataHelps (17% of calls; 18/109), and confusion with
the text messaging system prompting the 6MWT (18% of
calls; 20/109). The median duration of support calls was 4
minutes (interquartile range: Q1 5 3; Q3 5 6).
Discussion
In this pilot study of older patients with AF who are smart-
phone users, we demonstrate the feasibility of using an
mHealth app and wearable activity monitor, such as a Fitbit
Charge 2 heart rate device, to conduct a complete geriatric
assessment, including cognitive, physical, and psychosocial
function, for up to 6 months. Demographic, clinical, and psy-
chosocial factors were not associated with adherence over 6
months, suggesting that remote monitoring for geriatric im-
pairments is feasible in a wide range of older patients with AF.
Geriatric impairments such as CI, depression, and frailty
are recognized for their potential impact on AF management
success and clinical outcomes and are included in the 2019
ACC guidelines as important factors in therapeutic
decision-making and because they may identify a subset of
patients who need closer monitoring because they are high
risk for poor medication adherence or falls.2,5–8,21 Despite
this, these factors are not systematically assessed during
routine clinical visits owing to time constraints. Our results
suggest that it is possible to remotely monitor older patients
with AF for changes in cognitive, physical, and psychosocial
status. We found that nearly all participants (.90%)
Table 1 Cohort Characteristics (N540)
Demographics
Age (years), mean (SD) 70.9 (4.8)
Female 15 (37.5)




CHA2DS2VASc score, mean (SD) 3.3 (0.9)
Bothered by 1 AF symptom in the past 4 weeks 7 (17.5)
On anticoagulant 34 (85.0)
Medical history
Heart failure 7 (17.5)
Bleeding 4 (10.0)
Stroke 3 (7.5)




Not frail 17 (42.5)
Fall in past 6 months 4 (10.0)
Cognitive impairment (MOCA  23) 7 (17.5)
Social isolation (MOS , 12) 3 (7.5)
Visual impairment 8 (20.0)
Hearing impairment 11 (27.5)
Depression (PHQ-9  5) 10 (25.0)
Anxiety (GAD-7  5) 8 (20.0)
Living alone 8 (20.0)
All values are n (%) unless otherwise noted.
AF5 atrial fibrillation; GAD5 generalized anxiety disorder; MOCA5 Mon-
treal Cognitive Assessment; MOS 5 Medical Outcomes Study; PHQ 5 Patient
Health Questionnaire.
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completed a single assessment, which would provide a clini-
cian with information on prevalence of impairments, and that
more than half of patients completed additional assessments
over 6 months, which would allow providers to observe
changes in cognitive or physical status over time. Impor-
tantly, these assessments were completed with minimal sup-
port from our staff (,10 minutes per participant).
To date, remote monitoring of older patients with cardio-
vascular disease has centered around activity monitoring
with little focus on cognitive or functional phenotyping.
With older adults increasingly engaging with technology
and telehealth visits,22 opportunities for mHealth assess-
ments are expanding.23 Several studies have captured single
components of a geriatric assessment, such as fall risk and
depression, in the context of disease management interven-
tions.24–26 However, remote administration of a more
complete geriatric assessment remains an untapped
resource for surveillance and identification of patients at
high risk for poor medication adherence and disease
management. Loh and colleagues27 pilot tested a remote
assessment of a geriatric assessment in older cancer patients
and their caregivers over 1 month. They reported 80% adher-
ence over 1 month, with high acceptability of the mobile
technologies reported by patients and their caregivers. Our
adherence rates at 30 days (75%) were similar to those
reported by Loh and colleagues, and we extend their findings
to include a complete geriatric assessment including mea-
sures of cognition, mood, and physical function over 6
months with over 50% adherence.
Previous studies have not reported on the frequency and
duration of support calls with patients using the mHealth
tools. We found that, on average, participants required 2 sup-
port calls or fewer for assistance with technology over the
6-month follow-up and that the median time of each call
was 4 minutes. Although in our small pilot study this was
manageable, in a large practice these calls could become
burdensome. Future studies should examine whether calls
wane over time as patients become more familiar with the
technology and the potential for outsourcing calls that are
strictly technology, not clinical, in nature.
The COVID-19 pandemic has radically transformed exist-
ing infrastructures of medical practice as clinics and hospitals
around the world have shifted to virtual means of patient care.
Various professional societies including the AHA, ACC, and
Heart Rhythm Society have released guidelines for triaging
nonurgent patient care, and further emphasize the importance
of converting to telemedicine whenever possible.28 Further-
more, regulatory bodies in the United States have relaxed
strict privacy regulations and now allow providers to use
potentially non-HIPAA-compliant modalities to conduct
virtual patient care,29 and the Centers for Medicare &
Medicaid Services have also drastically expanded the range
of permissive contexts to conduct health care via telemedi-
cine.30 Increasing use of telemedicine and, eventually, im-
provements in reimbursement for telemedicine may also
promote the implementation of mHealth monitoring systems
like the one pilot tested in this study.
There is also consensus among some heart rhythm special-
ists that reverting to previous models of health care after the
pandemic is unlikely for the foreseeable future.31 Advanced
age and cardiac comorbidities are significant risk factors
for COVID-19-related complications, making AF patients
an especially vulnerable group, thus further highlighting
the importance of a safe and effective means to conduct
necessary clinical assessments for these patients.32 The
pandemic response adaptations made by healthcare systems
in embracing telemedicine have also lowered the infrastruc-
tural and implementation barriers traditionally faced by vir-
tual patient care, and COVID-19-era remote monitoring
strategies for AF patients are already being rapidly imple-
mented in numerous hospitals around the world.33 We






























Survey and Walk Test Adherance over 180 Days
Completed all survey data Completed Walk
[                N=40             ] [                                                    N=29                                                          ]
Figure 2 Survey and walk test adherence.
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geriatric assessments remotely, which can provide invaluable
data for clinical decision-making in the context of telemedi-
cine and enrich the remote patient experience.
This study has a number of strengths. Our geriatric assess-
ment was composed of validated measures adapted for our
study mobile application. The study sample was diverse with
respect to age and included participants over 85 years old,
and with respect to cognitive and functional status. Our
approach, after the initial visitwhenweassisted the participants
in the app download, was completely automated, including
preprogrammed text messages, and thus is scalable to large
populations. However, the results should be interpreted with
several limitations in mind. We did not collect data on accept-
ability of the app or measures, and future studies should
examine this in addition to adherence. Our pilot sample was
modest in size and exclusively non-Hispanic white and
English-speaking; thus our pilot results should be examined
in a larger and more diverse sample. In addition, our sample
was composed of smartphone users, so the results cannot be
extended to non-users. There were differences in the character-
istics of patients who participated in 1 vs 6months of our study
and thus longer follow-up in a larger sample is necessary to
confirm and expand findings. Finally, our pilot study sample
was a subset of an ongoing prospective study.
Conclusion
In this pilot study of older participants with AF, we show it is
feasible to administer a full geriatric assessment remotely
multiple times over a 6-month period. Importantly, these
assessments are feasible with minimal support in a range of
patients, including the oldest-old and those with cognitive
and functional impairments. Our pilot study was designed
only to determine the feasibility of assessing geriatric ele-
ments remotely. The results lay the groundwork for larger-
scale studies of how remote geriatric assessments could be
incorporated into in-office and telemedicine management of
patients with AF or into large-scale cohort studies or clinical
trials.
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